Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CENTOGENE logo — Empowering precision medicine through advanced diagnosis 

CENTOGENE

Empowering precision medicine through advanced diagnosis 

Founded 2006 Germany Rostock, Germany 475 employees IPO Total: $91.80M Biotechnology, Health Care

General Information

Company Name CENTOGENE
Founded Year 2006
Location Germany Rostock, Germany
Founders / Decision Makers
Team member
Employees 475
Industries Biotechnology, Health Care
Funding Stage IPO
Business Model B2B, SaaS, B2B2C
Revenue Model Service Fee, Data Monetization, Project Based
Offices as of Sep 2026
Rostock, Germany Dubai, United Arab Emirates Berlin, Germany Greater Noida, India Cambridge, United States São Paulo, Brazil Ciudad de México, Mexico
Social

BounceWatch is an independent company data service, not affiliated with CENTOGENE. To contact CENTOGENE, visit centogene.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CENTOGENE compare?

A PDF of CENTOGENE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CENTOGENE soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CENTOGENE

CENTOGENE, headquartered in Germany, is a pioneer in genetic diagnostics and precision medicine. Dedicated to converting clinical, genetic, and biochemical data into actionable medical solutions, the company champions the early diagnosis and treatment of rare diseases.

Since its founding in 2006, CENTOGENE has expanded its reach to over 100 countries, developing diagnostic capabilities for more than 2,500 rare diseases. Its impressive genetic database encompasses data from over 1,000,000 individuals, solidifying its position as a global leader. The company's dedication to research is evidenced by over 350 scientific publications.

Recently, CENTOGENE received a $20.00M Post IPO Equity investment from Lifera on 01 May 2024, underscoring investor confidence in its strategic direction and innovation capabilities. The company remains a crucial ally for physicians and a sought-after partner for pharmaceutical companies targeting orphan diseases.

Business keywords: genetic diagnostics, precision medicine, rare diseases, genetic testing, biochemical diagnostics, genetic data interpretation, pharmaceutical partnerships, orphan diseases, next generation sequencing, biomarkers, clinical studies, genetic data analysis, whole exome sequencing, whole genome sequencing, prenatal testing

Services & Products

Whole Genome Sequencing
Multiomic Solutions
Clinical Trial Support
Genetic Testing
Bioinformatics Solutions
Patient Identification
Customized Diagnostics

Target Customers

Physicians Pharmaceutical Companies Researchers Medical Institutions Patients with Rare Diseases

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity $20.00M 1
Lifera
01 May 2024
Post IPO Convertible $30.00M 1
Lifera
01 Jun 2023
Post-IPO Debt $16.80M 3
Deutsche Private Equity TVM Capital Life Science Careventures
Deutsche Private Equity, TVM Capital Life Science +1
01 Feb 2022
Secondary Market Undisclosed -
01 Jul 2020
IPO Undisclosed -
01 Nov 2019
Series A €25.00M 4
Deutsche Private Equity TVM Capital Life Science Crédit Mutuel Equity
Deutsche Private Equity, TVM Capital Life Science +2
01 Jun 2017

CENTOGENE Alternatives & Competitors

View All Alternatives
CENTOGENE vs
MEDGENOME
MEDGENOME India

Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions

Series D
1011 employees
Biotechnology, Health Care
Compare CENTOGENE vs MEDGENOME
CENTOGENE vs
Galatea Bio Inc.
Galatea Bio Inc. United States

Harnessing diversity to advance biopharma discovery and precision medicine

Venture round
37 employees
AI, Big Data
Compare CENTOGENE vs Galatea Bio Inc.
CENTOGENE vs
Mendelics
Mendelics Brazil

Análise genômica ao alcance de todos

154 employees
Biotechnology, Health Care
Also compare with: CENTOGENE vs Dhiti Omics Dhiti Omics View all alternatives

FAQ About CENTOGENE

Empowering precision medicine through advanced diagnosis 
CENTOGENE was founded in 2006.
CENTOGENE is headquartered in Rostock, Germany. As of Sep 2026, it also has offices in Dubai, United Arab Emirates, Berlin, Germany, Greater Noida, India, Cambridge, United States and São Paulo, Brazil.
CENTOGENE operates in Biotechnology and Health Care. Its work centres on genetic diagnostics, precision medicine, rare diseases and genetic testing. Its customers include Physicians, Pharmaceutical Companies and Researchers.
CENTOGENE has a B2B, SaaS and B2B2C business model. Its revenue comes from Service Fee, Data Monetization and Project Based.
CENTOGENE has approximately 475 employees.
CENTOGENE has completed 6 funding rounds, raising a total of $91.80M. The latest funding stage is IPO.
CENTOGENE offers: Whole Genome Sequencing, Multiomic Solutions, Clinical Trial Support, Genetic Testing, Bioinformatics Solutions, Patient Identification, Customized Diagnostics.
Top alternatives and competitors to CENTOGENE include MEDGENOME, Galatea Bio Inc., Mendelics, Solid Biosciences, CGC Genetics / CGC Centro Genetica Clinica. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CENTOGENE and MEDGENOME are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CENTOGENE, https://bouncewatch.com/company/centogene, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes